Table 1.
Characteristics | Population (N = 34) |
---|---|
Median age, y (range) | 59 (26-82) |
Sex, male, n (%) | 24 (71) |
ECOG performance status, n (%) | |
0 | 7 (21) |
1 | 24 (71) |
2 | 3 (9) |
Median number of prior therapies, n (range) | 4 (1-10) |
Prior stem cell transplantation, n (%) | 14 (41) |
Disease type/subtype, n (%) | |
Diffuse large B-cell lymphoma (DLBCL) | 12 (41) |
Classical Hodgkin lymphoma (HL) | 8 (24) |
Follicular lymphoma (FL) | 5 (12) |
Mantle cell lymphoma (MCL) | 3 (6) |
Chronic lymphocytic leukemia (CLL/SLL) | 2 (6) |
Anaplastic large cell lymphoma (ALCL) | 1 (3) |
Marginal zone lymphoma (MZL) | 1(3) |
Natural killer (NK)/T-cell lymphoma (TCL) | 1 (3) |
Peripheral T-cell lymphoma (PTCL) | 1 (3) |